This content is only available within our institutional offering.

22 Feb 2024
Hikma Pharmaceuticals: FY23 results: in line and positive outlook

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals: FY23 results: in line and positive outlook
Hikma Pharmaceuticals Plc (HIK:LON) | 1,782 -142.6 (-0.4%) | Mkt Cap: 3,954m
- Published:
22 Feb 2024 -
Author:
Paul Cuddon | Kane Slutzkin -
Pages:
4 -